🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I study of second primary tumor prevention in early stage (...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2007-08
Trial ID
NCT00400374
RATIONALE: Celecoxib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University of Miami Sylvester Comprehensive Cancer Center - Miami
Start Date
2004-03
Trial ID
NCT00450736
Treatments Being Tested
PD-1(programmed death protein 1)antibody has been to approved in patients w...
Status
Unknown
Location
Gastrointestinal Hospital, Sun Yat-sen University
Start Date
2018-08-23
Trial ID
NCT03638297
Treatments Being Tested
The PICC-3 study is a multicentre, single-arm, phase II trial evaluating to...
Status
Recruiting
Location
The Sixth Affiliated Hospital, Sun Yat-sen University
Start Date
2025-06-01
Trial ID
NCT06903858
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells....
Status
Completed
Location
Memorial Hospital Cancer Center
Start Date
2002-07
Trial ID
NCT00046839
Treatments Being Tested
The purpose of the study is to find out whether the drug celecoxib has bene...
Status
Terminated
Location
Indiana University Hospital
Start Date
2005-09
Trial ID
NCT00198081
Background: Inflammation plays a significant role in various disorders tha...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-06-14
Trial ID
NCT03912428
Treatments Being Tested
In extrahepatic bile duct cancer and pancreatic cancer, we will treat posto...
Status
Unknown
Location
Ho-Seong Han
Start Date
2008-11
Trial ID
NCT01111591
Treatments Being Tested
This randomized phase II trial studies how well celecoxib works in preventi...
Status
Completed
Location
Cleveland Clinic Foundation
Start Date
2004-11
Trial ID
NCT00099047
Treatments Being Tested